DataMEDS AI, Inc.: CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid

DataMeds AI, Inc. (MEDS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update ■ Health Lives Here app launch with NFL Alumni Health expected in September 2026 ■ Revenues grew 14% reaching $1.779M in Q2/26, beating management projections ■ Corporate name change from

DataMeds AI (MEDS) said it signed an amended letter of intent to gain control of Tollo Health, license QOLPOM-related IP from EOS Technology Holdings and Scilex, and expand its Datavault AI Health license. Consideration is in common stock only. EOS, Scilex, Datavault AI and HealthBridge Advisors are expected to hold about 84.6% post-closing, Fortitude about 5%, subject to adjustments. Closing depends on definitive deals, financing, approvals and Nasdaq.

Datavault AI (NASDAQ:DVLT) said it amended its definitive agreement with DataMeds AI (NASDAQ:MEDS) to expand a PharmacyChain blockchain technology licensing relationship into unencumbered commercial healthcare, healthspan and wellness uses. Datavault AI will receive common shares worth about 19.9% of DataMeds’ stock at closing, replacing preferred shares for tax optimization.

DataMeds AI (NASDAQ:MEDS) said it amended its licensing agreement with Datavault AI (NASDAQ:DVLT) to expand PharmacyChain blockchain-related licensing from pharmaceutical distribution to all unencumbered commercial healthcare, healthspan and wellness uses. The deal is tied to a pending multi-party combination and includes DVLT receiving common shares worth about 19.9% of MEDS at closing.

Billionaire Ernesto Bertarelli indirectly purchased 8.8 million shares of Madison Air Solutions (MAIR) at $24.97 per share, totaling $219 million. The acquisition was made through K.C. Armada, LP, bringing his indirect ownership to 11% of the company. MAIR's stock closed at $28.51, a 14% premium over the purchase price. The company has a market cap of $14.3 billion and expects 18% revenue growth this fiscal year.

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.